Zunsemetinib (ATI-450) is an orally active and selective inhibitor of the p38alpha mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway.Zunsemetinib is used to study spondyloarthritis and rheumatoid arthritis.
Molecular Weight:
513.92
Purity:
99.77%
CAS Number:
[1640282-42-3]
Formula:
C25H22ClF2N5O3
Target:
MAPK
T39126
* VAT and and shipping costs not included. Errors and price changes excepted